Danaher Corp. closed 35.83% below its 52-week high of $281.70, which the company reached on August 1st.

Andvari Associates, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can ...

We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Fintel reports that on April 10, 2025, Barclays upgraded their outlook for Danaher (NYSE:DHR) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 40.08% Upside As of April 2, 2025, the ...

Valued at a market cap of $129.9 billion, Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services. This Washington ...

Under the umbrella of Fisher Asset Management, Billionaire Ken Fisher has maintained a positive stance on technology stocks, ...

Stock futures are firmly lower, pulling back from yesterday's historic gains as investors unpack inflation data ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE ...

The Global Nucleic Acid Isolation and Purification Market is segmented into drug discovery & development, precision medicine, diagnostics, agriculture and animal research, and other, based on ...

The US Single-Cell Analysis Market is projected to reach US$2,695.3 million by 2029 from an estimated US$1,378.6 million in 2024, at a CAGR ...